[ad_1]
Analytics
Dealmaker Securities
Equity – Preferred
$155,000,000
Healthcare & Pharmaceuticals
Monogram Orthopaedics, with a valuation of $155 million, is raising funds on DealMaker Securities. The company is developing a product solution architecture to allow the personalization of orthopedic implants. Monogram Orthopaedics uses 3D printing and robotics through automated digital image analysis algorithms. The Monogram Knee System has won FDA approval and is solving real problems by revolutionizing joint replacement technology. Dr. Douglas Unis founded Monogram Orthopaedics in 2016. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development.
Summary Profit and Loss Statement
Revenue |
$628,246 |
$0 |
COGS |
$458,675 |
$0 |
Tax |
$0 |
$0 |
|
||
|
||
Net Income |
$-11,814,968 |
$-9,068,006 |
Summary Balance Sheet
Cash |
$5,535,710 |
$5,586,748 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$8,715,366 |
$8,115,888 |
Short-Term Debt |
$0 |
$0 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$0 |
$0 |
Financials as of: 07/15/2022
Raise History
Monogram Orthopaedics | 10/31/2022 | Dealmaker Securities | $155,000,000 | $0 | Equity – Preferred |
Active |
RegCF |
Monogram Orthopaedics | 02/18/2022 | StartEngine | $89,000,000 | $23,648,853 | Equity – Preferred |
Funded |
RegA+ |
Monogram Orthopaedics | 01/16/2021 | StartEngine | $89,900,000 | $2,965,501 | Equity – Preferred |
Funded |
Test the Waters / RegA+ |
Monogram Orthopaedics | 03/31/2020 | SeedInvest | $21,250,000 | $14,588,668 | Equity – Preferred |
Funded |
RegA+ |
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd’s quantitative ratings on all raises.
- Plan Includes:
-
Everything in Free, plus
- Company specific
“>
KingsCrowd ratings (excluding risk)
- Advanced company search (
with ratings) “>
Markets page filters and historical industry data-
Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd’s qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed
“>
Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports- In-depth risk ratings for every raise
-
Get Edge Pro Annual
Edge Pro
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Thank you for your vote on Monogram Orthopaedics on DealMaker Securities 2022
Thank you for your vote on Monogram Orthopaedics on DealMaker Securities 2022
[ad_2]